Treatment of Hepatocellular Carcinoma with Child-Pugh C Cirrhosis

Background: In most guidelines, no other interventional therapy but liver transplantation is recommended for the treatment of hepatocellular carcinoma (HCC) with Child-Pugh C cirrhosis (CP-C). However, in Japan, patients were sometimes treated with expectation of benefit. Summary: A workshop was con...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2014-01, Vol.87 (Suppl 1), p.99-103
Hauptverfasser:	Nouso, Kazuhiro, Kokudo, Norihiro, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nishikawa, Hiroki, Toyoda, Hidenori, Oishi, Naoki, Kuwaki, Kenji, Kusanaga, Masashi, Sakaguchi, Takuki, Morise, Zenichi, Kitai, Satoshi, Kudo, Masatoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Carcinoma, Hepatocellular - complications Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic Chemotherapy, Cancer, Regional Perfusion Hepatic Artery Humans Japan Liver cancer Liver cirrhosis Liver Cirrhosis - complications Liver Cirrhosis - pathology Liver Cirrhosis - therapy Liver Neoplasms - complications Liver Neoplasms - pathology Liver Neoplasms - therapy Neoplasm Staging Practice Patterns, Physicians' - statistics & numerical data Review Surveys and Questionnaires Transplants & implants Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!